MedTrace Logo

Clinical Evaluation in Real Life of TLC-NOSF Dressings in the Local Treatment of Chronic Wounds (DFU and VLU)

NCT06135987 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2023-11-18

No results posted yet for this study

Summary

The objective of this study is to document the performance and the safety of UrgoStart Plus® Border, UrgoStart Plus® Pad and UrgoStart Interface® in the local treatment of diabetic foot ulcers (neuropathic or neuroischemic - non-critical ischemia) and venous or mixed predominantly venous leg ulcers, in real life conditions and current practice, in France.

Conditions

  • Real Life Study
  • TLC-NOSF Dressings
  • Venous Leg Ulcer
  • Diabetic Foot Ulcer
  • QoL Questionnaire

Interventions

DEVICE

TLC-NOSF dressings (D'URGOSTART PLUS® BORDER, URGOSTART PLUS® PAD and URGOSTART INTERFACE®)

Clinical evaluation of the dressing in the local treatment of chronic wounds (DFU and VLU)

Sponsors & Collaborators

  • Laboratoires URGO

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-24
Primary Completion
2024-06-30
Completion
2024-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06135987 on ClinicalTrials.gov